Similarly, MMP2 and MMP9 function as the key mediator of VM in glioma, while the suppression of Tenascin‐c attenuates AKT phosphorylation, and downregulates MMP2 and MMP9 expression, thus repressing VM in gliomas.52 The gene discussed is AKT1; the disease is central nervous system cancer.